This is a narrative-only filing with no hard financial data. Traders should monitor the next quarterly or annual report for tangible metrics on user growth, GMV, or revenue progression under the AI strategy. Until then, no actionable catalyst is present.
Price Chart
Executive Summary
POMDOCTOR issued a press release reiterating its AI-enabled chronic disease management strategy, citing third-party market research on growth in AI healthcare and chronic disease management markets. No financial results, guidance, or material operational updates were provided.
Key Facts
- POM is focusing on integrating AI, remote patient monitoring (RPM), wearable technologies, and real-world data into a predictive healthcare ecosystem.
- The press release cites third-party market forecasts: AI chronic disease prevention market projected from $30.2B (2026) to $488.4B by 2035; chronic disease management tech market from $7.21B (2025) to $15.01B by 2033.
- No company-specific financial data, revenue, earnings, or guidance were disclosed.
- The 20-F annual report filed on May 14, 2026 provides the financial context for this strategy update.
Financial Impact
Not specified
Risk Factors
- Forward-looking strategy with no quantified milestones or revenue impact — execution risk is high for a micro-cap.
- Intense competition in AI healthcare and chronic disease management; no proprietary advantage evidenced in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-076538 |
| Document: ea0297497-6k_pomdoctor.htm | 0001213900-26-076538 |
| Document: 0001213900-26-076538-index-headers.html | 0001213900-26-076538 |
| Document: 0001213900-26-076538-index.html | 0001213900-26-076538 |
| Document: 0001213900-26-076538.txt | 0001213900-26-076538 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 6-K | $0.5314 $1.13 | ▲ +112.65% | ▲ +112.79% | $1.13 (+112.65%) |
Oct 9, 2026 17d ago | 6-K | $0.6210 $0.5310 | ▲ +14.49% | ▲ +13.00% | $1.13 (−81.96%) |
Sep 30, 2026 26d ago | 6-K | $0.9350 $0.8490 | ▼ −9.20% | ▼ −11.11% | $1.13 (+20.86%) |
Sep 24, 2026 4w ago | 6-K | $0.9700 $0.9200 | ▼ −5.15% | ▼ −4.74% | $1.13 (+16.49%) |
Sep 10, 2026 6w ago | 6-K | $0.7423 $0.8290 | ▲ +11.68% | ▲ +12.18% | $1.13 (+52.23%) |
Aug 27, 2026 8w ago | 6-K | $0.9501 $0.8696 | ▼ −8.47% | ▼ −8.74% | $1.13 (+18.93%) |
Aug 10, 2026 11w ago | 6-K | $1.09 $0.8755 | ▼ −19.68% | ▼ −19.63% | $1.13 (+3.67%) |
Aug 3, 2026 12w ago | 6-K | $0.6880 $1.09 | ▲ +58.43% | ▲ +56.40% | $1.13 (+64.24%) |
Jul 15, 2026 14w ago | 6-K | $1.51 $0.8011 | ▼ −46.95% | ▼ −45.97% | $1.13 (−25.17%) |
Jul 13, 2026 15w ago | 6-K | $1.42 $1.13 | ▼ −20.42% | ▼ −19.64% | $1.13 (−20.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers